Correlation Between HCW Biologics and Entrada Therapeutics
Can any of the company-specific risk be diversified away by investing in both HCW Biologics and Entrada Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HCW Biologics and Entrada Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HCW Biologics and Entrada Therapeutics, you can compare the effects of market volatilities on HCW Biologics and Entrada Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HCW Biologics with a short position of Entrada Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of HCW Biologics and Entrada Therapeutics.
Diversification Opportunities for HCW Biologics and Entrada Therapeutics
-0.2 | Correlation Coefficient |
Good diversification
The 3 months correlation between HCW and Entrada is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding HCW Biologics and Entrada Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Entrada Therapeutics and HCW Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HCW Biologics are associated (or correlated) with Entrada Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Entrada Therapeutics has no effect on the direction of HCW Biologics i.e., HCW Biologics and Entrada Therapeutics go up and down completely randomly.
Pair Corralation between HCW Biologics and Entrada Therapeutics
Given the investment horizon of 90 days HCW Biologics is expected to generate 27.68 times more return on investment than Entrada Therapeutics. However, HCW Biologics is 27.68 times more volatile than Entrada Therapeutics. It trades about 0.15 of its potential returns per unit of risk. Entrada Therapeutics is currently generating about 0.19 per unit of risk. If you would invest 46.00 in HCW Biologics on August 26, 2024 and sell it today you would earn a total of 31.00 from holding HCW Biologics or generate 67.39% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
HCW Biologics vs. Entrada Therapeutics
Performance |
| Timeline |
| HCW Biologics |
| Entrada Therapeutics |
HCW Biologics and Entrada Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with HCW Biologics and Entrada Therapeutics
The main advantage of trading using opposite HCW Biologics and Entrada Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HCW Biologics position performs unexpectedly, Entrada Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entrada Therapeutics will offset losses from the drop in Entrada Therapeutics' long position.| HCW Biologics vs. Anebulo Pharmaceuticals | HCW Biologics vs. Rezolute | HCW Biologics vs. Eliem Therapeutics | HCW Biologics vs. Molecular Partners AG |
| Entrada Therapeutics vs. Eliem Therapeutics | Entrada Therapeutics vs. HCW Biologics | Entrada Therapeutics vs. Scpharmaceuticals | Entrada Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |